To hear about similar clinical trials, please enter your email below
Trial Title:
iCanWork: A Randomized Controlled Trial
NCT ID:
NCT05546736
Condition:
Cancer-related Problem/Condition
Survivorship
Quality of Life
Conditions: Keywords:
return to work
cancer survivors
vocational rehabilitation
randomized controlled trial
Study type:
Interventional
Study phase:
N/A
Overall status:
Not yet recruiting
Study design:
Allocation:
Randomized
Intervention model:
Parallel Assignment
Primary purpose:
Supportive Care
Masking:
Double (Participant, Outcomes Assessor)
Intervention:
Intervention type:
Behavioral
Intervention name:
iCanWork Intervention
Description:
Participants will receive RTW support from the VRC and OT.
Arm group label:
iCanWork Intervention
Summary:
The aim of this study is to evaluate the effectiveness of the iCanWork intervention in
assisting cancer survivors (CS) to return to work (RTW) and its impact on their
health-related quality of life (QoL), health service utilization, RTW readiness, time to
RTW, and work capacity.
Detailed description:
The iCanWork intervention comprises several elements related to health and work, taken
from the latest reviews that recommend a remote and individual intervention, led by a
vocational rehabilitation counsellor (VRC), experts in assisting RTW for CS. The
intervention includes 6 sessions with a VRC and 1-4 sessions with an occupational
therapist (OT). A total of 270 CS will be recruited into 2 groups (intervention or
control). The duration of this study is 24 months. Study participants will complete
electronic questionnaires measuring study variables at baseline before randomization and
at 6-month, 12-month, 18-month, and 24-month follow-ups.
Criteria for eligibility:
Criteria:
Inclusion Criteria:
- diagnosed with cancer (all types) treated with curative intent and of working age
(between 18 and 65 at the time of diagnosis)
- gainfully employed at the time of diagnosis (full or part-time, including students)
- still on sick leave, including long-term disability leave, but for less than 2 years
- has not started to return to work, since stopping due to cancer
- can read and understand English or French
- reside in Canada.
Exclusion Criteria:
- If the cancer survivor's physicians consider returning to work unwise, such as due
to a metastatic cancer diagnosis
Gender:
All
Minimum age:
18 Years
Maximum age:
65 Years
Healthy volunteers:
No
Locations:
Facility:
Name:
McGill University
Address:
City:
Montréal
Zip:
H3A 0G4
Country:
Canada
Contact:
Last name:
Christine Maheu, PhD
Phone:
514-398-1906
Email:
christine.maheu@mcgill.ca
Start date:
April 1, 2023
Completion date:
September 1, 2026
Lead sponsor:
Agency:
McGill University
Agency class:
Other
Source:
McGill University
Record processing date:
ClinicalTrials.gov processed this data on November 12, 2024
Source: ClinicalTrials.gov page:
https://clinicaltrials.gov/ct2/show/NCT05546736
